NCT07098364
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +20 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Refractory Indolent B-Cell Non-Hodgkin Lymphoma
Explore clinical trials studying Refractory Indolent B-Cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
2 public trials
2 recruiting studies
Refractory Indolent B-Cell Non-Hodgkin Lymphoma trial results
NCT06386315
- Conditions
- Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent Indolent Non-Hodgkin Lymphoma, +2 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
- Mayo Clinic Health System - Mankato Mankato, Minnesota, United States